The Australian Guide to the diagnosis of FASD

This Guide has been produced to assist clinicians in the diagnosis, referral and management of Fetal Alcohol Spectrum Disorder (FASD).

Bottom right Shape

The Australian Guide to the Diagnosis of FASD was developed to facilitate and standardise the diagnosis of FASD in Australia. It provides clinicians with diagnostic criteria for Fetal Alcohol Spectrum Disorder (FASD), which were agreed following review of existing guidelines and consultation with clinical experts.

The diagnosis of FASD is complex, and ideally requires a multidisciplinary team of clinicians to evaluate individuals for prenatal alcohol exposure, neurodevelopmental problems and facial abnormalities in the context of a general physical and developmental assessment.

Alternative diagnoses must be considered, including genetic diagnoses and exposure to other teratogens. FASD may co-exist with these and other conditions. The impact on neurodevelopment of both physical and psychosocial postnatal exposures such as early life trauma must also be considered.

The Australian Guide to the diagnosis of FASD was released 5 May 2016 and updated 13 May 2016 and February 2020.

An updated version of the Australian Guidelines for Assessment and Diagnosis of Fetal Alcohol Spectrum Disorder (FASD) or Neurodevelopmental Disorder Associated with Prenatal Alcohol Exposure (ND/PAE) is currently under review. Public consultation closed 21 April 2024.

The Australian Guide to Diagnosis of FASD

Access the Guide
Bottom right Shape

Individual sections of the Australian Guide to diagnosis of FASD (February 2020)

A diagnosis of FASD requires evidence of prenatal alcohol exposure and severe impairment in three or more domains of central nervous system structure or function.

A diagnosis of FASD can be divided into one of two sub-categories:

  1. FASD with three sentinel facial features
  2. FASD with less than three sentinel facial features

FASD with three sentinel facial features replaces the diagnosis of Fetal Alcohol Syndrome, but without a requirement for growth impairment. FASD with less than three sentinel facial features encompasses the previous categories of Partial Fetal Alcohol Syndrome and Neurodevelopmental Disorder-Alcohol Exposed).

The aetiological role of alcohol is most clearly established in the presence of all three characteristic facial abnormalities. In this situation a diagnosis of FASD with three sentinel facial features can be made even when prenatal alcohol exposure is unknown, provided there is also severe neurodevelopmental impairment.

Read more:

Table 1: Diagnostic criteria and categories
Figure 1: Diagnostic algorithm

 

 

The timing, frequency and quantity of prenatal alcohol exposure are linked to the pattern and severity of fetal outcomes. Brain growth and development occur throughout pregnancy hence adverse cognitive, behavioural and neurodevelopmental outcomes may result from exposure at any time during pregnancy, and may occur in the absence of facial anomalies or structural central nervous system abnormalities.

When detailed information on maternal alcohol use is available, consumption during pregnancy should be assessed using the AUDIT-C questions, which provide a standardised method for assessment of maternal alcohol use and are based on a validated sex-specific version of the instrument.

Read more:

Section A: Assessing maternal alcohol use

Table 2: Alcohol Use Disorders Identification Test – Consumption (AUDIT-C)

 

 

In FASD, 10 domains of neurodevelopment have been identified that reflect areas of brain function known to be affected by prenatal alcohol exposure based on evidence from human and animal research, and clinical experience. The following domains should be assessed as part of the diagnostic evaluation for FASD:

  1. Brain structure/Neurology
  2. Motor skills
  3. Cognition
  4. Language
  5. Academic achievement
  6. Memory
  7. Attention
  8. Executive function, including impulse control and hyperactivity
  9. Affect regulation
  10. Adaptive behaviour, social skills or social communication

The clinical cut-off for severe impairment is defined either as a global score, or a major subdomain score on a standardised validated neurodevelopmental scale that is 2 or more standard deviations below the mean (≤2 SD), or less than the 3rd percentile (<3rd PC). Clinical judgement should be used to determine whether severe impairment is present is a range of situations.

Read more:

Section B: Assessing neurodevelopmental impairment

Table 3: Neurodevelopmental domains: Criteria for severe impairment 

Fetal exposure to alcohol during the first trimester affects the development of the facial features. The areas most affected are the eyes and midface. The three facial features are:

  1. Small palpebral fissures: short horizontal length of the eye opening, defined as the distance from the endocanthion to the exocathanion
  2. Smooth philtrum: diminished or absent ridges between the upper lip and nose
  3. Thin upper lip: with small volume

Most people with FASD do not have the three sentinel facial features.

Read more:

Section C: Assessing sentinel facial features

Growth assessment is an important aspect of any paediatric examination and impairment may reflect a teratogenic insult, genetic or other prenatal or postnatal factors. However, growth impairment is no longer considered diagnostic of FASD due to the range of factors which can influence growth in an individual in combination with prenatal alcohol exposure. Recent evidence and clinical experience suggest that growth impairment is neither sensitive nor sufficiently specific to indicate a FASD diagnosis.

Read more:

Section D: Growth assessment

Information collected during the diagnostic assessment should be reviewed, ideally in a multi-disciplinary team context, to evaluate the strength of evidence to:

  • support a diagnosis of FASD with 3 sentinel facial features or a diagnosis of FASD with less than 3 sentinel facial features; or
  • consider whether the individual is at risk of FASD, requiring reassessment and/or further investigation; or
  • exclude other causes of conditions; and/or
  • assess the potential influence of other exposures and events

Read more:

Section E: Formulating a diagnosis

Information on co-existing conditions or other syndromes can be found in Appendix D of the Australian Guide to the diagnosis of FASD.

The FASD Diagnostic Assessment Form (Appendix A1) and the Summary Form (Appendix A2) summarise the clinical findings required to make a diagnosis of FASD.

 

After the diagnostic assessment, irrespective of the diagnosis, it is recommended that the health professional/s coordinating the diagnostic process:

  • discuss with the individual/parents/caregivers the outcome of the assessments
  • discuss the diagnosis and develop a management plan, incorporating parent/caregiver and patient goals, referrals, management strategies and review dates
  • provide the individual/parents/caregivers with a written report
  • discuss how this information may be important to share with relevant service providers

Read more:

Section F: Discussing the diagnosis and developing a management plan

Appendix A3: Australian FASD Management Plan Form

Appendix A6: Information for clinicians: Issues that individuals and their caregivers may experience during the FASD assessment process

Appendix A8: Information and resources for clinicians after a diagnostic assessment

Bottom Left ShapeBottom right Shape

Assessment & Diagnosis: Training Opportunities

Person wearing yellow jumper typing on their laptop.

FASD eLearning Modules

Access self-paced eLearning modules for health professionals involved in FASD assessment and diagnosis.

person in a brightly lit room pointing at a wall covered in sticky notes with other people sitting at a desk with laptops looking in the same direction

FASD Hub Clinical Workshop

Register to access the materials to host a FASD Clinical Workshop training sessions.

Reporting a FASD Diagnosis

The FASD Australian Registry

The aim of the Fetal Alcohol Spectrum Disorder Australian Registry (FASDAR) is to collect detailed information about children under 15 years in Australia with FASD. Data from the FASDAR will inform clinical, diagnostic and treatment guidelines, policies, and programmes to improve outcomes for children with FASD and their families.

Parents and carers can register their interest by visiting the FASDAR website.

Learn more

The Australian Paediatric Surveillance Unit

The Australian Paediatric Surveillance Unit (APSU) monitors rare childhood conditions that include congenital/genetic disorders, infectious/vaccine preventable conditions, mental health and other injuries. FASD is one of the studies on the APSU Report Card.

Learn more

WA Register of Developmental Anomalies (WARDA)

FASD is a notifiable birth defect in Western Australia.

WARDA collects information to keep track of where and when developmental anomalies are occurring in WA. This information also guides research and helps to investigate causes, prevention and management of developmental anomalies.

Learn more

The South Australian Birth Defects Register (SABDR)

FASD is a notifiable birth defect in South Australia.

The South Australian Birth Defects Register (SABDR) collects information on all children born in South Australia who have a significant birth defect detected in the first five years of life.

Learn more

Acknowledgements

This research was conducted by the Australian FASD Collaboration.

Lead Investigators

  • Winthrop Research Professor Carol Bower, Telethon Kids Institute, The University of Western Australia
  • Professor Elizabeth Elliott AM, University of Sydney and the Children’s Hospital at Westmead

Senior Consultants

  • Dr Lucinda Burns, Nationa Drug and Alcohol Research Centre, University of NSW
  • Ms Maureen Carter, Nindilingarri Cultural Health Services, Fitzroy Crossing WA
  • Ms Heather D’Antoine, Menzies School of Health Research, Charles Darwin University
  • Dr James Fitzpatrick, The George Institute for Global Health, University of Sydney
  • Assoc Prof Jane Halliday, Murdoch Childrens Research Institute, University of Melbourne
  • Ms Lorian Hayes, Centre for Chronic Disease, University of Queensland
  • Assoc Prof Jane Latimer, George Institute for Global Health, University of Sydney
  • Ms Anne Mckenzie, Telethon Kids Institute and School of Population Health, The University of Western Australia
  • Ms Sue Miers AM, National Organisation for Fetal Alcohol Spectrum Disorders Australia
  • Dr Raewyn Mutch, Telethon Kids Institute , The University of Western Australia and Child and Adolescent Health Service WA Department of Health
  • Dr Colleen O’Leary, Centre for Population Health Research Curtin University and Telethon Kids Institute
  • Dr Jan Payne, Telethon Kids Institute , The University of Western Australia
  • Dr Elizabeth Peadon, Children’s Hospital at Westmead
  • Ms Anne Russell, Russell Family Fetal Alcohol Disorders Association
  • Dr Amanda Wilkins, Telethon Kids Institute, The University of Western Australia and Child and Adolescent Health Service WA Department of Health

Project Team

  • Ms Heather Jones, Telethon Kids Institute, The University of Western Australia
  • Dr Rochelle Watkins, Telethon Kids Institute, The University of Western Australia

Researchers

  • Professor Carol Bower, Principal Senior Research Fellow Telethon Kids Institute
  • Professor Elizabeth Elliott, Professor in Paediatrics and Child Health University of Sydney
  • Dr Rochelle Watkins, Senior Research Fellow Telethon Kids Institute

National Steering Group

  • Professor Carol Bower (Chair): Principal Senior Research Fellow Telethon Kids Institute
  • Mr Scott Avery: Director Policy and Research First Peoples Disability Network
  • Dr Felicity Collins: Head Department of Clinical Genetics Sydney Children’s Hospital Network (Westmead)
  • Dr Jennifer Delima: Director Addiction and Clinical Forensic Medicine Alcie Springs Hospital
  • Professor Elizabeth Elliott: Paediatrician Sydney Children’s Hospital Network (Westmead) and Professor in Paediatrics and Child Health
  • Dr James Fitzpatrick*: Paediatrician and McCusker Clinical Research Fellow Telethon Kids Institute
  • Ms Andrea Lammel: Brain Mind Research Institute Faculty of Health University of Sydney
  • Ms Vicki Russell*: Chief Executive Officer National Organisation for Fetal Alcohol Spectrum Disorders Australia
  • Dr Doug Shelton*: Paediatrician, Clinical Director Community Child Health and Medical Director Children’s Services
  • Dr Linda So: Paediatrician Representative Royal Australian College of Physicians
  • Dr David Thomas: Paediatrician Representative Royal Australian College of Physicians
  • Dr Amanda Wilkins*: Paediatrician WA Child Development Service and Honorary Clinical Research Fellow Telethon Kids Institute
  • Dr Marcel Zimmet: Paediatrician, Sydney Children’s Hospital Network (Westmead)

* Also member of the Expert Review Panel

Expert Review Panel

An Expert Review Panel was formed to provide specific expertise on diagnosis.

  • Professor Elizabeth Elliott (Chair): Sydney Children’s Hospital Network (Westmead) and Professor in Paediatrics and Child Health
  • Dr Marcel Zimmet: Paediatrician, Sydney Children’s Hospital Network (Westmead)
  • Professor Carol Bower: Principal Senior Research Fellow Telethon Kids Institute
  • Dr James Fitzpatrick: Paediatrician and McCusker Clinical Research Fellow Telethon Kids Institute
  • Dr Amanda Wilkins: Paediatrician WA Child Development Service and Honorary Clinical Research Fellow Telethon Kids Institute
  • Dr Doug Shelton: Paediatrician, Clinical Director Community Child Health and Medical Director Children’s Services
  • Ms Vicki Russell: Chief Executive Officer, National Organisation for Fetal Alcohol Spectrum Disorders Australia

Project staff

  • Ms Juanita Doorey

Stay connected

Join our mailing list to hear more from the FASD Hub, including our monthly newsletters, webinar invitations, and new publications.

Loading

Acknowledgement of Country

FASD Hub Australia acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of Country throughout Australia, and we recognise their connections to land, water and community. We pay our respect to their elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander peoples.

Top Left ShapeLeft Center Shape